Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

NCT00286793 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ascenta Therapeutics